Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating dose response from flexible dose clinical trials.

Ilya Lipkovich1, David H Adams, Craig Mallinckrodt

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis Indiana, USA. lipkovichia@lilly.com

BMC Psychiatry
|January 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
Same author

Spectral EEG-guided adaptive neuromodulation for social anxiety disorder, performance-only subtype: a case report.

Frontiers in psychiatry·2026
Same author

Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases.

Statistics in medicine·2026
Same author

Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?

British journal of healthcare and medical research·2026
Same author

Neurogenetics and Epigenetics of Spirituality and Religion: Seeking Genospirituality Via the Lens of Hierarchical Neuro-Spiritual Model (HNSM).

Neurology (E-Cronicon)·2026
Same author

Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.

Current pharmaceutical biotechnology·2026
Same journal

Whose suffering counts? Research funding, scientific freedom, and the epistemic erasure of sexual and gender diverse children.

BMC psychiatry·2026
Same journal

Association between gastrointestinal diseases and depression severity among middle-aged and older Chinese women: the mediating effect of sleep duration.

BMC psychiatry·2026
Same journal

Depression and anxiety symptom severity correlates with subjective fatigue characteristics in individuals with anxiety and mood disorders.

BMC psychiatry·2026
Same journal

Developing a core competency framework for community-based psychiatric rehabilitation practitioners in China: a modified Delphi study.

BMC psychiatry·2026
Same journal

The relationship between social media addiction and metacognitions in patients with social anxiety disorder.

BMC psychiatry·2026
Same journal

Next of kin involvement in mental health care services - a systematic participatory overview of evidence syntheses.

BMC psychiatry·2026
See all related articles

Flexible-dose trials may show misleading efficacy results. Marginal structural models with inverse probability of treatment weighting (MSM, IPTW) can correct biases and reveal true dose effects in olanzapine studies.

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Biostatistics

Background:

  • Dose-outcome relationships can obscure true effects in flexible-dose trials.
  • Unadjusted analyses may yield biased efficacy findings.

Purpose of the Study:

  • To evaluate dose-response effects of olanzapine in bipolar mania and schizophrenia.
  • To assess the utility of marginal structural models with inverse probability of treatment weighting (MSM, IPTW) for bias correction.

Main Methods:

  • Utilized data from two randomized, double-blind, flexible-dose trials of olanzapine.
  • Applied MSM, IPTW methodology with time-dependent weights to adjust for non-random dose assignment and dropouts.
  • Compared weighted analyses with unweighted analyses.

Related Experiment Videos

Main Results:

  • Unweighted analyses favored lower doses, suggesting a negative dose effect.
  • Weighted analyses revealed no strong dose effects and, in some cases, reversed the apparent negative dose effect.
  • MSM, IPTW approach mitigated biases observed in unweighted analyses.

Conclusions:

  • Naïve dose comparisons in flexible-dose trials can lead to significant bias.
  • MSM with IPTW estimators is a valuable method for unbiased dose-effect evaluation.
  • This methodology can aid in planning future confirmatory trials.